Bright Minds Biosciences (DRUG) Interest & Investment Income (2024 - 2026)
Bright Minds Biosciences (DRUG) reported Interest & Investment Income of $2.6 million for Q1 2026, up 614.57% on a YoY basis from $358005.3 in Q1 2025, and up 335.98% quarter-over-quarter from $586766.6 in Q4 2025.
Bright Minds Biosciences (DRUG) Interest & Investment Income (2024 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Interest & Investment Income for 3 years, with the latest figure at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 614.57% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 614.57% YoY), and the FY2025 full-year result was $1.1 million, up 4898.39% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.6 million, up from $586766.6 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.6 million in Q1 2026, with the low at $3091.0 in Q4 2024.
- Historically, Interest & Investment Income has averaged $706356.0 across 3 years, with a median of $472386.0 in 2025.
- Annual changes were most pronounced in 2025 — Interest & Investment Income surged 18882.84% — and 2026, when it jumped 614.57%.
- Bright Minds Biosciences' Interest & Investment Income stood at $3091.0 in 2024, then surged by 18882.84% to $586766.6 in 2025, then jumped by 335.98% to $2.6 million in 2026.
- The last three Interest & Investment Income figures came in at $2.6 million (Q1 2026), $586766.6 (Q4 2025), and $714444.9 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Bright Minds Biosciences | 16.42 Bn | 16.36 Bn | - | 2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.56 Mn |
| Dec 31, 2025 | 586,766.61 |
| Jun 30, 2025 | 714,444.85 |
| Mar 31, 2025 | 358,005.30 |
| Dec 31, 2024 | 3,091.04 |
| Jun 30, 2024 | 17,639.50 |